Intervacc
1 known investors
Intervacc is a Swedish biotech company that develops animal health vaccines based on fusions of recombinant proteins, including Strangvac® against strangles in horses. Through its subsidiaries Nordvacc Läkemedel and Mybac-Vettech Laboratoriet, it sells animal vaccines on the European animal health market.
Investors · 1
Frequently asked questions
- What does Intervacc do?
- Intervacc is a Swedish biotech company that develops animal health vaccines based on fusions of recombinant proteins, including Strangvac® against strangles in horses. Through its subsidiaries Nordvacc Läkemedel and Mybac-Vettech Laboratoriet, it sells animal vaccines on the European animal health market.
- Who are Intervacc's investors?
- Intervacc's investors include HealthCap.